Category: Drug Safety Alerts
-
Serevent, Advair, and Foradil: Despite The Increased Risk of Severe Asthma Episodes and Death, Monotherapy Use Continues
Numerous Safety Warnings From FDA About These LABA Asthma Drugs Have Seemingly Been Ignored By Patients, According To New Medco Study (Posted by Tom Lamb at DrugInjuryWatch.com) As some of you may recall, back…
-
Study About Using Glaxo’s Avodart To Prevent Prostate Cancer Finds Possible Heart Risk
Higher Rate Of Cardiac Failure In Men Taking Avodart (Dutasteride) – 0.7 Percent vs. 0.4 Percent For Those Taking The Placebo (Posted by Tom Lamb at DrugInjuryWatch.com) In the April 1, 2010 edition of…
-
Antibiotic Avelox Linked To Severe Liver Injury Side Effects, Again
Will The FDA Be The Last To Insist On Increased Warning; In Fall 2007 Bayer Updated Its Avalox Label In Europe (Posted by Tom Lamb at DrugInjuryWatch.com) On March 22, 2010 Health Canada issued a press…
-
March 2010: FDA Warns About Highest Dose Of Zocor Causing Myopathy And Rhabdomyolysis
Active Ingredient Simvastatin Is Found In Vytorin, With Zetia, And Simcor, With Niacin, Also (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor…
-
FDA And Novartis Announce A Label Change For Iron Chelating Drug Exjade In Mid-February 2010
Includes A New "Black Box" Warning About Renal Impairment, Liver Failure, And Gastrointestinal Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 the FDA and Novartis announced a change to the Prescribing Information…
-
Recent Report About Ortho Evra Safety Seems To Contradict Earlier Findings From Same Group
Third Boston Collaborative Drug Surveillance Program Study Analysis Concerning Ortho Evra And Blood Clot Side Effect Risk Causes Confusion (Posted by Tom Lamb at DrugInjuryWatch.com)Let us start with this relatively recent medical journal article, "Postmarketing study of…
-
Some Fosamax Users Have Had Their Femur Fracture Without Any Fall Or Other Trauma
Reports About Sudden Breaking Of Thigh Bone In Patients Using Fosamax For Five Years Or More (Posted by Tom Lamb at DrugInjuryWatch.com) _______________________________________________________________________________________________________ UPDATE: Fosamax Femur Fracture Warning Label Change By Merck Seems Likely…
-
Case Report: Man Using Diabetes Medication Januvia Develops Elevated Hepatic Enzymes
Authors Suggest That Certain Patients Starting Januvia Should Have Their Liver Function Monitored (Posted by Tom Lamb at DrugInjuryWatch.com) In the recent past we considered whether Januvia (sitagliptin) can cause pancreatitis in patients using…
-
Fibromyalgia Drug Savella Should Be Pulled From Market, Says Public Citizen Group
January 2010 Petition Letter To FDA Is Sent One Year After The Medication Was Approved For Sale In U.S. (Posted by Tom Lamb at DrugInjuryWatch.com) On January 21, 2010 the Health Research Group arm…
-
Should Meridia Remain On Market? FDA Says “Yes” (For Now At Least), European Drug Regulators Say “No”
Difference Of Opinion Suggests There Could Be A Possible Meridia Recall In U.S. Before The FDA Holds Its Public Advisory Meeting In September 2010(Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Abbott Pulls Meridia in U.S. Amid…